 Thomas Schroeppel
Concepts (401)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 31 | 2023 | 772 | 5.870 |
Why?
| | Trauma Centers | 35 | 2023 | 388 | 4.130 |
Why?
| | Brain Injuries | 9 | 2023 | 484 | 3.310 |
Why?
| | Injury Severity Score | 38 | 2023 | 528 | 3.090 |
Why?
| | Wounds, Nonpenetrating | 13 | 2023 | 285 | 2.510 |
Why?
| | Rib Fractures | 3 | 2021 | 27 | 2.160 |
Why?
| | Brain Injuries, Traumatic | 10 | 2023 | 318 | 1.990 |
Why?
| | Retrospective Studies | 64 | 2023 | 12978 | 1.900 |
Why?
| | Abdominal Injuries | 10 | 2023 | 119 | 1.720 |
Why?
| | Trauma Severity Indices | 6 | 2022 | 127 | 1.630 |
Why?
| | Hospital Mortality | 14 | 2022 | 814 | 1.620 |
Why?
| | Length of Stay | 19 | 2022 | 1032 | 1.600 |
Why?
| | Intracranial Hemorrhage, Traumatic | 2 | 2020 | 6 | 1.530 |
Why?
| | Adrenergic beta-Antagonists | 5 | 2018 | 301 | 1.410 |
Why?
| | General Surgery | 7 | 2022 | 134 | 1.410 |
Why?
| | Triage | 5 | 2023 | 203 | 1.310 |
Why?
| | Glasgow Coma Scale | 13 | 2023 | 150 | 1.280 |
Why?
| | Anticoagulants | 7 | 2023 | 559 | 1.270 |
Why?
| | Adult | 71 | 2023 | 31512 | 1.160 |
Why?
| | Appendicitis | 3 | 2020 | 125 | 1.120 |
Why?
| | Wounds, Penetrating | 6 | 2021 | 77 | 1.070 |
Why?
| | Stroke | 4 | 2023 | 1047 | 1.010 |
Why?
| | Primary Dysautonomias | 2 | 2014 | 2 | 1.000 |
Why?
| | Humans | 114 | 2023 | 118974 | 0.980 |
Why?
| | Propranolol | 2 | 2014 | 54 | 0.980 |
Why?
| | Intensive Care Units | 12 | 2021 | 635 | 0.980 |
Why?
| | Venous Thromboembolism | 3 | 2023 | 234 | 0.970 |
Why?
| | Warfarin | 3 | 2023 | 139 | 0.970 |
Why?
| | Vital Capacity | 2 | 2021 | 260 | 0.930 |
Why?
| | Critical Care | 5 | 2023 | 492 | 0.930 |
Why?
| | Aged | 44 | 2022 | 19657 | 0.930 |
Why?
| | Postpartum Hemorrhage | 1 | 2023 | 16 | 0.920 |
Why?
| | Female | 85 | 2023 | 61565 | 0.920 |
Why?
| | Time-to-Treatment | 2 | 2021 | 149 | 0.920 |
Why?
| | Contusions | 1 | 2023 | 21 | 0.900 |
Why?
| | Practice Guidelines as Topic | 5 | 2023 | 1440 | 0.890 |
Why?
| | Male | 82 | 2023 | 57801 | 0.880 |
Why?
| | Hospitalization | 7 | 2023 | 1785 | 0.860 |
Why?
| | Cholecystitis, Acute | 4 | 2023 | 16 | 0.850 |
Why?
| | Middle Aged | 54 | 2023 | 27617 | 0.810 |
Why?
| | Decompressive Craniectomy | 2 | 2018 | 11 | 0.810 |
Why?
| | Advance Directives | 1 | 2022 | 62 | 0.790 |
Why?
| | Transfusion Reaction | 1 | 2021 | 79 | 0.790 |
Why?
| | Laparotomy | 7 | 2023 | 106 | 0.780 |
Why?
| | Appendix | 2 | 2018 | 28 | 0.770 |
Why?
| | Craniocerebral Trauma | 1 | 2022 | 146 | 0.740 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 231 | 0.740 |
Why?
| | Recovery of Function | 4 | 2020 | 604 | 0.740 |
Why?
| | Surgeons | 2 | 2023 | 243 | 0.740 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2020 | 402 | 0.730 |
Why?
| | Blood Transfusion | 7 | 2023 | 306 | 0.710 |
Why?
| | Patient Admission | 1 | 2021 | 176 | 0.700 |
Why?
| | Cholecystectomy, Laparoscopic | 3 | 2023 | 44 | 0.690 |
Why?
| | Laparoscopy | 5 | 2022 | 417 | 0.690 |
Why?
| | Internship and Residency | 3 | 2015 | 1001 | 0.680 |
Why?
| | Thoracic Injuries | 5 | 2023 | 63 | 0.680 |
Why?
| | Duodenum | 2 | 2016 | 67 | 0.680 |
Why?
| | Propofol Infusion Syndrome | 1 | 2018 | 1 | 0.670 |
Why?
| | Choledocholithiasis | 3 | 2019 | 14 | 0.650 |
Why?
| | Resuscitation | 6 | 2023 | 253 | 0.650 |
Why?
| | Workload | 3 | 2020 | 128 | 0.630 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 278 | 0.620 |
Why?
| | Wounds, Gunshot | 6 | 2023 | 176 | 0.620 |
Why?
| | Hemorrhage | 6 | 2023 | 623 | 0.620 |
Why?
| | Disease Management | 3 | 2018 | 571 | 0.610 |
Why?
| | Head Injuries, Closed | 3 | 2016 | 55 | 0.600 |
Why?
| | Tomography, X-Ray Computed | 9 | 2022 | 2436 | 0.580 |
Why?
| | Prospective Studies | 26 | 2023 | 6471 | 0.570 |
Why?
| | Treatment Outcome | 28 | 2023 | 9342 | 0.570 |
Why?
| | Blood Component Transfusion | 3 | 2022 | 84 | 0.570 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 338 | 0.560 |
Why?
| | Pneumonia, Ventilator-Associated | 5 | 2015 | 41 | 0.550 |
Why?
| | Sutures | 1 | 2016 | 61 | 0.540 |
Why?
| | Critical Illness | 5 | 2018 | 662 | 0.530 |
Why?
| | Risk Assessment | 13 | 2022 | 3057 | 0.520 |
Why?
| | Suture Techniques | 1 | 2016 | 134 | 0.510 |
Why?
| | Survival Rate | 7 | 2021 | 1720 | 0.500 |
Why?
| | Prognosis | 9 | 2022 | 3443 | 0.500 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 126 | 0.490 |
Why?
| | United States | 23 | 2023 | 12555 | 0.490 |
Why?
| | Forecasting | 1 | 2016 | 353 | 0.480 |
Why?
| | Emergency Medical Services | 6 | 2022 | 589 | 0.470 |
Why?
| | Brain Concussion | 1 | 2020 | 470 | 0.460 |
Why?
| | Anesthetics, Intravenous | 1 | 2013 | 34 | 0.460 |
Why?
| | Nursing Assessment | 1 | 2013 | 46 | 0.460 |
Why?
| | Cholecystitis | 2 | 2023 | 17 | 0.450 |
Why?
| | Young Adult | 17 | 2021 | 10793 | 0.450 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2021 | 176 | 0.450 |
Why?
| | Propofol | 1 | 2013 | 49 | 0.450 |
Why?
| | Tennessee | 5 | 2016 | 44 | 0.430 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1510 | 0.430 |
Why?
| | Emergency Service, Hospital | 7 | 2023 | 1865 | 0.410 |
Why?
| | Logistic Models | 9 | 2022 | 1901 | 0.410 |
Why?
| | Emergencies | 3 | 2022 | 153 | 0.410 |
Why?
| | Respiration, Artificial | 3 | 2022 | 545 | 0.370 |
Why?
| | Quality Improvement | 1 | 2017 | 963 | 0.360 |
Why?
| | Neuroprotective Agents | 1 | 2010 | 111 | 0.360 |
Why?
| | Fibrinolytic Agents | 2 | 2022 | 238 | 0.350 |
Why?
| | Postoperative Complications | 8 | 2021 | 2235 | 0.350 |
Why?
| | Follow-Up Studies | 8 | 2020 | 4596 | 0.350 |
Why?
| | Algorithms | 4 | 2021 | 1541 | 0.340 |
Why?
| | Firearms | 3 | 2023 | 281 | 0.340 |
Why?
| | Carbon Dioxide | 2 | 2022 | 230 | 0.340 |
Why?
| | Embolization, Therapeutic | 2 | 2022 | 192 | 0.340 |
Why?
| | Emergency Treatment | 2 | 2020 | 110 | 0.330 |
Why?
| | Medical Errors | 1 | 2009 | 89 | 0.330 |
Why?
| | Time Factors | 7 | 2020 | 6412 | 0.320 |
Why?
| | Aged, 80 and over | 13 | 2022 | 6561 | 0.320 |
Why?
| | Cohort Studies | 8 | 2023 | 5116 | 0.310 |
Why?
| | Clinical Protocols | 2 | 2019 | 238 | 0.310 |
Why?
| | Hospital Charges | 1 | 2007 | 42 | 0.300 |
Why?
| | Seasons | 1 | 2009 | 461 | 0.290 |
Why?
| | Pregnancy, Tubal | 1 | 2006 | 4 | 0.290 |
Why?
| | Hemoperitoneum | 1 | 2006 | 13 | 0.280 |
Why?
| | Abdomen, Acute | 1 | 2006 | 20 | 0.280 |
Why?
| | Appendectomy | 2 | 2020 | 73 | 0.280 |
Why?
| | Cervical Vertebrae | 2 | 2019 | 115 | 0.280 |
Why?
| | Fallopian Tubes | 1 | 2006 | 28 | 0.280 |
Why?
| | Regression Analysis | 3 | 2021 | 983 | 0.280 |
Why?
| | Colorado | 5 | 2022 | 4196 | 0.280 |
Why?
| | Hemothorax | 3 | 2023 | 10 | 0.270 |
Why?
| | Cholecystectomy | 3 | 2023 | 45 | 0.270 |
Why?
| | Registries | 7 | 2021 | 1810 | 0.270 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2005 | 27 | 0.260 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2005 | 7 | 0.260 |
Why?
| | Severity of Illness Index | 5 | 2022 | 2674 | 0.260 |
Why?
| | Predictive Value of Tests | 5 | 2022 | 1868 | 0.260 |
Why?
| | Risk Factors | 7 | 2020 | 9000 | 0.260 |
Why?
| | Shock, Hemorrhagic | 2 | 2019 | 206 | 0.250 |
Why?
| | Adolescent | 20 | 2023 | 18480 | 0.250 |
Why?
| | Incidence | 9 | 2020 | 2424 | 0.250 |
Why?
| | Chest Tubes | 2 | 2023 | 34 | 0.250 |
Why?
| | Patient Readmission | 2 | 2020 | 634 | 0.250 |
Why?
| | Geriatric Assessment | 2 | 2022 | 185 | 0.250 |
Why?
| | Abdominal Cavity | 1 | 2023 | 5 | 0.240 |
Why?
| | Multivariate Analysis | 6 | 2020 | 1474 | 0.240 |
Why?
| | Abdomen | 4 | 2023 | 110 | 0.240 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2014 | 1945 | 0.240 |
Why?
| | Abdominal Abscess | 1 | 2023 | 27 | 0.240 |
Why?
| | Anastomosis, Surgical | 3 | 2023 | 146 | 0.240 |
Why?
| | Linear Models | 2 | 2021 | 827 | 0.240 |
Why?
| | Gastric Bypass | 1 | 2005 | 93 | 0.230 |
Why?
| | Spleen | 3 | 2012 | 510 | 0.230 |
Why?
| | Factor Xa Inhibitors | 2 | 2022 | 138 | 0.230 |
Why?
| | Leg Injuries | 1 | 2023 | 23 | 0.230 |
Why?
| | Erythrocyte Transfusion | 3 | 2014 | 210 | 0.230 |
Why?
| | Cerebrovascular Trauma | 1 | 2023 | 14 | 0.220 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 77 | 0.220 |
Why?
| | Pregnancy | 2 | 2023 | 5691 | 0.220 |
Why?
| | Blood Coagulation | 2 | 2023 | 219 | 0.220 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2023 | 54 | 0.220 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2019 | 16 | 0.220 |
Why?
| | Intraabdominal Infections | 1 | 2022 | 3 | 0.220 |
Why?
| | Tibial Fractures | 1 | 2023 | 71 | 0.210 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2022 | 11 | 0.210 |
Why?
| | Administration, Oral | 2 | 2023 | 756 | 0.210 |
Why?
| | Obesity, Morbid | 1 | 2005 | 197 | 0.210 |
Why?
| | Tourniquets | 1 | 2022 | 27 | 0.210 |
Why?
| | Liver | 4 | 2023 | 1816 | 0.200 |
Why?
| | Thrombolytic Therapy | 1 | 2022 | 118 | 0.200 |
Why?
| | Enoxaparin | 1 | 2021 | 51 | 0.200 |
Why?
| | Comorbidity | 3 | 2022 | 1527 | 0.200 |
Why?
| | Platelet Transfusion | 1 | 2022 | 68 | 0.200 |
Why?
| | Coagulants | 1 | 2021 | 12 | 0.200 |
Why?
| | Accidental Falls | 2 | 2020 | 154 | 0.200 |
Why?
| | Diverticulitis, Colonic | 1 | 2020 | 8 | 0.200 |
Why?
| | Resource Allocation | 1 | 2021 | 38 | 0.200 |
Why?
| | Extremities | 1 | 2022 | 113 | 0.190 |
Why?
| | Colorectal Surgery | 1 | 2020 | 22 | 0.190 |
Why?
| | Pneumonia, Bacterial | 2 | 2015 | 110 | 0.190 |
Why?
| | Thoracostomy | 1 | 2020 | 18 | 0.190 |
Why?
| | Patient Discharge | 4 | 2022 | 796 | 0.190 |
Why?
| | Wilderness | 1 | 2020 | 17 | 0.190 |
Why?
| | Mountaineering | 1 | 2020 | 47 | 0.190 |
Why?
| | Colectomy | 1 | 2020 | 84 | 0.180 |
Why?
| | Frailty | 1 | 2022 | 116 | 0.180 |
Why?
| | Hypoventilation | 1 | 2019 | 7 | 0.180 |
Why?
| | Peptic Ulcer Perforation | 1 | 2019 | 2 | 0.180 |
Why?
| | Physician's Role | 1 | 2022 | 200 | 0.180 |
Why?
| | Omentum | 1 | 2019 | 11 | 0.180 |
Why?
| | Prisoners | 1 | 2022 | 128 | 0.180 |
Why?
| | Cross Infection | 2 | 2015 | 205 | 0.180 |
Why?
| | Head Injuries, Penetrating | 1 | 2019 | 8 | 0.180 |
Why?
| | Reproducibility of Results | 4 | 2022 | 2874 | 0.180 |
Why?
| | Surgical Procedures, Operative | 1 | 2022 | 215 | 0.170 |
Why?
| | Skin Diseases, Infectious | 1 | 2019 | 16 | 0.170 |
Why?
| | Drug Utilization | 1 | 2020 | 169 | 0.170 |
Why?
| | Herniorrhaphy | 1 | 2019 | 52 | 0.170 |
Why?
| | Wound Infection | 1 | 2019 | 31 | 0.170 |
Why?
| | Age Factors | 4 | 2020 | 2995 | 0.170 |
Why?
| | Postoperative Care | 1 | 2020 | 237 | 0.170 |
Why?
| | Terminal Care | 1 | 2022 | 187 | 0.170 |
Why?
| | Soft Tissue Infections | 1 | 2019 | 30 | 0.170 |
Why?
| | Practice Patterns, Physicians' | 4 | 2020 | 1200 | 0.170 |
Why?
| | Neck Injuries | 1 | 2019 | 20 | 0.170 |
Why?
| | Creatine Kinase | 1 | 2018 | 75 | 0.160 |
Why?
| | Cause of Death | 3 | 2019 | 380 | 0.160 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1384 | 0.160 |
Why?
| | Acute Disease | 3 | 2023 | 940 | 0.160 |
Why?
| | Fractures, Bone | 1 | 2023 | 380 | 0.160 |
Why?
| | Survival Analysis | 4 | 2014 | 1267 | 0.160 |
Why?
| | Traumatology | 1 | 2018 | 24 | 0.160 |
Why?
| | Surgical Wound Infection | 1 | 2020 | 251 | 0.160 |
Why?
| | Insurance Coverage | 1 | 2019 | 208 | 0.160 |
Why?
| | Organ Size | 1 | 2018 | 460 | 0.160 |
Why?
| | Endosonography | 1 | 2019 | 142 | 0.150 |
Why?
| | Point-of-Care Testing | 1 | 2017 | 31 | 0.150 |
Why?
| | Mothers | 1 | 2023 | 682 | 0.150 |
Why?
| | Renal Dialysis | 1 | 2021 | 378 | 0.150 |
Why?
| | Physical Examination | 1 | 2019 | 243 | 0.150 |
Why?
| | Bronchoalveolar Lavage | 2 | 2015 | 89 | 0.150 |
Why?
| | Health Care Costs | 1 | 2020 | 394 | 0.150 |
Why?
| | Chi-Square Distribution | 4 | 2012 | 525 | 0.150 |
Why?
| | Lactic Acid | 1 | 2018 | 282 | 0.140 |
Why?
| | Drug Administration Schedule | 2 | 2020 | 736 | 0.140 |
Why?
| | Confidence Intervals | 2 | 2014 | 324 | 0.140 |
Why?
| | Enteral Nutrition | 2 | 2015 | 170 | 0.140 |
Why?
| | Jejunostomy | 1 | 2015 | 13 | 0.140 |
Why?
| | Respiratory Function Tests | 1 | 2017 | 526 | 0.140 |
Why?
| | Common Bile Duct | 2 | 2023 | 14 | 0.130 |
Why?
| | Vascular System Injuries | 1 | 2016 | 70 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2022 | 628 | 0.130 |
Why?
| | Decision Making | 1 | 2022 | 809 | 0.130 |
Why?
| | Rehydration Solutions | 1 | 2014 | 8 | 0.130 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 81 | 0.130 |
Why?
| | Isotonic Solutions | 1 | 2014 | 43 | 0.130 |
Why?
| | Monitoring, Physiologic | 3 | 2019 | 272 | 0.130 |
Why?
| | Spinal Fractures | 1 | 2016 | 77 | 0.130 |
Why?
| | Erythrocyte Indices | 1 | 2014 | 29 | 0.130 |
Why?
| | Pain | 1 | 2020 | 735 | 0.120 |
Why?
| | Odds Ratio | 2 | 2014 | 996 | 0.120 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2016 | 181 | 0.120 |
Why?
| | Societies, Medical | 1 | 2018 | 703 | 0.120 |
Why?
| | Athletic Injuries | 1 | 2020 | 495 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 2 | 2019 | 100 | 0.120 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2013 | 17 | 0.120 |
Why?
| | Hospitals, University | 1 | 2014 | 172 | 0.120 |
Why?
| | Sensitivity and Specificity | 3 | 2019 | 1795 | 0.120 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2013 | 190 | 0.120 |
Why?
| | Rhabdomyolysis | 1 | 2013 | 18 | 0.110 |
Why?
| | Ultrasonography | 2 | 2023 | 716 | 0.110 |
Why?
| | Stents | 1 | 2016 | 457 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 794 | 0.110 |
Why?
| | Nutritional Support | 1 | 2012 | 28 | 0.110 |
Why?
| | Syndrome | 1 | 2013 | 344 | 0.110 |
Why?
| | Infusions, Intravenous | 2 | 2010 | 380 | 0.110 |
Why?
| | Statistics, Nonparametric | 4 | 2019 | 403 | 0.110 |
Why?
| | Acidosis | 1 | 2013 | 86 | 0.110 |
Why?
| | Child | 8 | 2023 | 19129 | 0.110 |
Why?
| | Rural Health Services | 1 | 2012 | 93 | 0.100 |
Why?
| | Multiple Trauma | 1 | 2012 | 97 | 0.100 |
Why?
| | Radiography, Thoracic | 2 | 2015 | 164 | 0.100 |
Why?
| | Wounds, Stab | 2 | 2008 | 11 | 0.100 |
Why?
| | Dietary Proteins | 1 | 2012 | 130 | 0.100 |
Why?
| | Nitrogen | 1 | 2012 | 154 | 0.100 |
Why?
| | Preoperative Care | 2 | 2012 | 332 | 0.100 |
Why?
| | Operative Time | 2 | 2023 | 114 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 1 | 2013 | 277 | 0.100 |
Why?
| | Critical Pathways | 2 | 2009 | 79 | 0.100 |
Why?
| | Tidal Volume | 2 | 2022 | 74 | 0.100 |
Why?
| | Sex Factors | 4 | 2020 | 1781 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2014 | 364 | 0.090 |
Why?
| | Sigmoidoscopy | 1 | 2009 | 10 | 0.090 |
Why?
| | Digital Rectal Examination | 1 | 2009 | 10 | 0.090 |
Why?
| | Analysis of Variance | 2 | 2012 | 1293 | 0.090 |
Why?
| | Intestinal Fistula | 1 | 2009 | 12 | 0.090 |
Why?
| | Cerebral Angiography | 2 | 2023 | 116 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2012 | 227 | 0.090 |
Why?
| | Databases, Factual | 1 | 2014 | 1231 | 0.090 |
Why?
| | Polytetrafluoroethylene | 1 | 2009 | 25 | 0.090 |
Why?
| | Craniotomy | 1 | 2009 | 69 | 0.080 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2008 | 11 | 0.080 |
Why?
| | Rectum | 1 | 2009 | 157 | 0.080 |
Why?
| | Coated Materials, Biocompatible | 1 | 2009 | 58 | 0.080 |
Why?
| | Splenic Rupture | 1 | 2008 | 5 | 0.080 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2008 | 63 | 0.080 |
Why?
| | Surgical Mesh | 1 | 2008 | 41 | 0.080 |
Why?
| | Intracranial Pressure | 1 | 2008 | 53 | 0.080 |
Why?
| | Blood Vessel Prosthesis | 1 | 2009 | 115 | 0.080 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 73 | 0.080 |
Why?
| | Diaphragm | 1 | 2008 | 36 | 0.080 |
Why?
| | Diazepam | 1 | 2008 | 23 | 0.080 |
Why?
| | Wisconsin | 2 | 2022 | 91 | 0.080 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 193 | 0.080 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1125 | 0.080 |
Why?
| | Central Nervous System Depressants | 1 | 2008 | 89 | 0.080 |
Why?
| | Hypnotics and Sedatives | 1 | 2008 | 136 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 709 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3174 | 0.070 |
Why?
| | Exsanguination | 2 | 2019 | 16 | 0.070 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2008 | 157 | 0.070 |
Why?
| | Pancreas | 1 | 2007 | 282 | 0.060 |
Why?
| | Calcium | 1 | 2011 | 1169 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2009 | 346 | 0.060 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 554 | 0.060 |
Why?
| | Hemoglobins | 1 | 2006 | 326 | 0.060 |
Why?
| | Anastomotic Leak | 1 | 2023 | 29 | 0.060 |
Why?
| | Ethanol | 1 | 2008 | 575 | 0.060 |
Why?
| | Patient Acuity | 1 | 2023 | 37 | 0.060 |
Why?
| | Fracture Fixation | 1 | 2023 | 81 | 0.050 |
Why?
| | Computed Tomography Angiography | 1 | 2023 | 81 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 296 | 0.050 |
Why?
| | Global Burden of Disease | 1 | 2022 | 15 | 0.050 |
Why?
| | Vital Signs | 1 | 2022 | 42 | 0.050 |
Why?
| | Frail Elderly | 1 | 2022 | 107 | 0.050 |
Why?
| | Mesentery | 1 | 2021 | 56 | 0.050 |
Why?
| | Alcoholism | 1 | 2008 | 717 | 0.050 |
Why?
| | Colon | 1 | 2023 | 238 | 0.050 |
Why?
| | Energy Intake | 2 | 2015 | 447 | 0.050 |
Why?
| | Factor Xa | 1 | 2021 | 31 | 0.050 |
Why?
| | International Classification of Diseases | 1 | 2022 | 122 | 0.050 |
Why?
| | Blood Coagulation Factors | 1 | 2021 | 43 | 0.050 |
Why?
| | Aftercare | 1 | 2022 | 194 | 0.050 |
Why?
| | Shock | 1 | 2022 | 92 | 0.050 |
Why?
| | Bronchoscopy | 2 | 2015 | 247 | 0.050 |
Why?
| | Thoracotomy | 1 | 2020 | 84 | 0.050 |
Why?
| | Chemoprevention | 1 | 2020 | 89 | 0.050 |
Why?
| | Heart Failure | 1 | 2013 | 1969 | 0.050 |
Why?
| | Child, Preschool | 3 | 2020 | 9491 | 0.050 |
Why?
| | Intestines | 1 | 2023 | 332 | 0.050 |
Why?
| | Drainage | 1 | 2020 | 157 | 0.050 |
Why?
| | Kidney | 1 | 2007 | 1353 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 2019 | 69 | 0.040 |
Why?
| | Lower Extremity | 1 | 2023 | 335 | 0.040 |
Why?
| | Hepatic Artery | 1 | 2019 | 55 | 0.040 |
Why?
| | Fasciitis | 1 | 2019 | 11 | 0.040 |
Why?
| | Bilirubin | 1 | 2019 | 95 | 0.040 |
Why?
| | Aspirin | 1 | 2022 | 334 | 0.040 |
Why?
| | Propensity Score | 1 | 2020 | 242 | 0.040 |
Why?
| | Neck Pain | 1 | 2019 | 24 | 0.040 |
Why?
| | Cellulitis | 1 | 2019 | 47 | 0.040 |
Why?
| | Southwestern United States | 1 | 2019 | 94 | 0.040 |
Why?
| | Needs Assessment | 1 | 2021 | 327 | 0.040 |
Why?
| | Angiography | 1 | 2019 | 185 | 0.040 |
Why?
| | Abscess | 1 | 2019 | 75 | 0.040 |
Why?
| | Staphylococcus epidermidis | 2 | 2009 | 70 | 0.040 |
Why?
| | Observer Variation | 1 | 2019 | 309 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 230 | 0.040 |
Why?
| | Reference Values | 1 | 2019 | 774 | 0.040 |
Why?
| | Spinal Injuries | 1 | 2019 | 53 | 0.040 |
Why?
| | Plasma | 1 | 2019 | 224 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2021 | 1308 | 0.040 |
Why?
| | Pain Management | 1 | 2020 | 294 | 0.040 |
Why?
| | Survivors | 1 | 2020 | 418 | 0.040 |
Why?
| | Infant | 2 | 2020 | 8293 | 0.040 |
Why?
| | Canada | 1 | 2018 | 340 | 0.040 |
Why?
| | Brachiocephalic Trunk | 1 | 2016 | 11 | 0.040 |
Why?
| | Axillary Artery | 1 | 2016 | 13 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 842 | 0.040 |
Why?
| | Ligation | 1 | 2016 | 82 | 0.040 |
Why?
| | Subclavian Artery | 1 | 2016 | 31 | 0.040 |
Why?
| | Angiography, Digital Subtraction | 1 | 2016 | 46 | 0.040 |
Why?
| | Carotid Artery Injuries | 1 | 2016 | 42 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 667 | 0.040 |
Why?
| | Orthotic Devices | 1 | 2016 | 30 | 0.030 |
Why?
| | Unnecessary Procedures | 1 | 2016 | 45 | 0.030 |
Why?
| | Leukopenia | 1 | 2015 | 27 | 0.030 |
Why?
| | False Negative Reactions | 1 | 2015 | 57 | 0.030 |
Why?
| | Leukocytosis | 1 | 2015 | 34 | 0.030 |
Why?
| | Acid-Base Imbalance | 1 | 2014 | 6 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2015 | 120 | 0.030 |
Why?
| | Pneumonia | 1 | 2020 | 592 | 0.030 |
Why?
| | Parenteral Nutrition | 1 | 2015 | 92 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2015 | 749 | 0.030 |
Why?
| | Erythrocyte Count | 1 | 2012 | 19 | 0.030 |
Why?
| | Nutritional Requirements | 1 | 2012 | 75 | 0.030 |
Why?
| | Brain | 1 | 2023 | 2490 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2012 | 132 | 0.020 |
Why?
| | Sigmoidoscopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 1798 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2012 | 294 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 613 | 0.020 |
Why?
| | Superinfection | 1 | 2009 | 5 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5255 | 0.020 |
Why?
| | Aminoglycosides | 1 | 2009 | 15 | 0.020 |
Why?
| | Adhesives | 1 | 2009 | 11 | 0.020 |
Why?
| | Minocycline | 1 | 2009 | 28 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3588 | 0.020 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 2008 | 5 | 0.020 |
Why?
| | Polyglactin 910 | 1 | 2008 | 10 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 196 | 0.020 |
Why?
| | Rifampin | 1 | 2009 | 69 | 0.020 |
Why?
| | Fasciotomy | 1 | 2008 | 20 | 0.020 |
Why?
| | Hyperplasia | 1 | 2009 | 170 | 0.020 |
Why?
| | Abdominal Wall | 1 | 2008 | 27 | 0.020 |
Why?
| | Decompression, Surgical | 1 | 2009 | 97 | 0.020 |
Why?
| | Gram-Negative Bacteria | 1 | 2008 | 70 | 0.020 |
Why?
| | Methacrylates | 1 | 2009 | 110 | 0.020 |
Why?
| | Compartment Syndromes | 1 | 2008 | 38 | 0.020 |
Why?
| | Body Mass Index | 1 | 2015 | 2092 | 0.020 |
Why?
| | Probability | 1 | 2008 | 305 | 0.020 |
Why?
| | Cost Savings | 1 | 2007 | 77 | 0.020 |
Why?
| | Pneumothorax | 1 | 2007 | 48 | 0.020 |
Why?
| | ROC Curve | 1 | 2008 | 473 | 0.020 |
Why?
| | Swine | 1 | 2009 | 730 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 965 | 0.020 |
Why?
| | Continuity of Patient Care | 1 | 2008 | 265 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2009 | 394 | 0.020 |
Why?
| | Pilot Projects | 1 | 2009 | 1419 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2009 | 3730 | 0.010 |
Why?
| | Animals | 1 | 2009 | 33381 | 0.000 |
Why?
|
|
Schroeppel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|